AI, drug discovery, and the future of healthcare innovation | Unusual Suspects
Share
Subscribe
AI is transforming the world, but how significantly has it revolutionized healthcare? Can it expedite drug discovery, personalize treatment, and reduce costs? In this episode of "Unusual Suspects," we speak with Mr. Raj Babu, the founder and CEO of Agilisium, a leader in AI-driven healthcare innovation. Raj discusses how Agilisium empowers researchers and pharmaceutical companies to address complex challenges, from digitizing supply chains for cell and gene therapy to facilitating breakthroughs in neonatal cancer research. He also discusses the ethical implications of AI, the democratization of innovation, and how startups are creating a more level playing field in healthcare. Take a listen!